You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

stroke, NOAC

Showing 1 - 25 of 8,854
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ischemic Strokes While on NOAC - How Compliance Matters

Recruiting
  • Stroke, Ischemic
  • +5 more
    • Hong Kong, Hong Kong
      Chinese University of Hong Kong
    Aug 4, 2022

    Ischemic Stroke, Anticoagulant Adverse Reaction Trial in Taipei (Dabigatran, rivaroxaban, apixaban, edoxaban)

    Recruiting
    • Ischemic Stroke
    • Anticoagulant Adverse Reaction
    • Dabigatran, rivaroxaban, apixaban, edoxaban
    • Taipei, Taiwan
      National Taiwan University Hospital
    Nov 22, 2023

    Monitoring of NOAC Therapy: Standardizing Reference Intervals

    Recruiting
    • Ischemic Stroke
    • +3 more
      • Hong Kong, Hong Kong
        Chinese University of Hong Kong
      May 18, 2022

      New Oral Anticoagulants (NOAC) in Stroke Patients

      Active, not recruiting
      • Stroke
      • Atrial Fibrillation
      • treatment with NOACs or VKAs
      • Basel, Switzerland
      • +1 more
      Dec 21, 2022

      Elderly Belgian NVAF That Are Treated WithNOAC for This

      Completed
      • Non-Valvular Atrial Fibrillation
      • Non-VKA Oral Anticoagulants (NOAC)
      • Multiple Locations, Belgium
        Many Locations
      Mar 21, 2022

      NOAC Portuguese Real World Study

      Withdrawn
      • Stroke
      • +2 more
      • (no location specified)
      Apr 8, 2022

      Intracerebral Hemorrhage Trial in Basel (Tranexamic acid, Saline 0.9%)

      Completed
      • Intracerebral Hemorrhage
      • Tranexamic acid
      • Saline 0.9%
      • Basel, Switzerland
        Stroke Center, University Hospital Basel
      Mar 22, 2022

      Learn More About Benefits and Side-effects of Drugs Rivaroxaban

      Completed
      • Atrial Fibrillation
      • Rivaroxaban (Xarelto, BAY59-7939)
      • +2 more
      • Many Sites, United Kingdom
        Many facilities
      Oct 27, 2021

      Stroke, Atrial Fibrillation Trial in Canada, Denmark (Investigators can choose from one of four Non-vitamin K oral

      Recruiting
      • Stroke
      • Atrial Fibrillation
      • Non-vitamin K oral anticoagulant (NOAC)
      • Concord, New South Wales, Australia
      • +46 more
      Oct 21, 2022

      Atrial Fibrillation Trial in Xi'an (Rivaroxaban 15mg, Aspirin 100mg, Clopidogrel 75mg)

      Recruiting
      • Atrial Fibrillation
      • Rivaroxaban 15mg
      • +4 more
      • Xi'an, Shannxi, China
        Ling Tao
      Jul 24, 2023

      Atrial Fibrillation, Stroke Trial in Worldwide (Left atrial appendage occlusion, NOAC)

      Recruiting
      • Atrial Fibrillation
      • Stroke
      • Left atrial appendage occlusion
      • NOAC
      • Aarhus, Central Denmark Region, Denmark
      • +11 more
      Jan 4, 2021

      Non-vitamin K Antagonist Oral Anticoagulant Therapy and Acute

      Recruiting
      • Therapeutic Drug Monitoring
      • Blood sampling to test drug level
      • Taipei, Taiwan
        National Taiwan University Hospital
      Mar 8, 2022

      Non-vitamin K Antagonist Oral Anticoagulant Concentration and

      Recruiting
      • Atrial Fibrillation
      • Data collection
      • Taipei, Please Select, Taiwan
      • +1 more
      Apr 17, 2022

      Registry of Acute Stroke Under Novel Oral Anticoagulants - Prime

      Completed
      • Ischemic Stroke
      • +4 more
      • not applicable (observational study)
      • Heidelberg, Germany
        University Hospital Heidelberg
      Nov 1, 2022

      Stroke Trial in United States (Time-To-Treatment Randomization)

      Recruiting
      • Stroke
      • Time-To-Treatment Randomization
      • Austin, Texas
      • +14 more
      Nov 2, 2022

      Atrial Fibrillation, Percutaneous Coronary Intervention Trial in Xi'an (The WATCHMAN/WATCHMAN FLX device, Rivaroxaban +

      Not yet recruiting
      • Atrial Fibrillation
      • Percutaneous Coronary Intervention
      • The WATCHMAN/WATCHMAN FLX device
      • +2 more
      • Xi'an, Shannxi, China
        Ling Tao
      Jul 20, 2022

      Atrial High Rate Episodes Trial in Multiple Locations (Edoxaban, ASA)

      Recruiting
      • Atrial High Rate Episodes
      • Multiple Locations, Austria
      • +16 more
      Jun 3, 2022

      Observes Usage of Non-vitamin K Antagonist Oral Anticoagulants

      Completed
      Has Results
      • Atrial Fibrillation
      • Non-vitamin K antagonist oral anticoagulant
      • Alcorcón, Madrid, Spain
      • +44 more
      Sep 2, 2021

      Thumb ECG IncidenT Atrial fibrillatioN in Diabetes Mellitus

      Recruiting
      • Diabetes Mellitus
      • Atrial Fibrillation
      • Coala Heart Monitor Pro
      • Gävle, Sweden
        Region Gavleborg
      Dec 13, 2021

      Oral Anticoagulation Drugs and How Well These Drugs Work in Real

      Active, not recruiting
      • Atrial Fibrillation
      • Rivaroxaban (Xarelto)
      • +3 more
      • Multiple Locations, Sweden
        Many locations
      Jan 20, 2023

      Coronary Artery Disease, Percutaneous Coronary Intervention, Acute Coronary Syndrome Trial in Beijing (Aspirin + Clopidogrel +

      Not yet recruiting
      • Coronary Artery Disease
      • +2 more
      • Aspirin + Clopidogrel + Rivaroxaban
      • Aspirin + Clopidogrel
      • Beijing, Beijing, China
        Chinese Academy of Medical Sciences, Fuwai Hospital
      Dec 5, 2022

      Atrial Fibrillation, Oral Anticoagulation, Stroke Trial (Vine Filter)

      Not yet recruiting
      • Atrial Fibrillation
      • +3 more
      • Vine Filter
      • (no location specified)
      Feb 14, 2023

      Atrial Fibrillation, Intracerebral Hemorrhage Trial in Canada (NOAC, Acetylsalicylic Acid)

      Completed
      • Atrial Fibrillation
      • Intracerebral Hemorrhage
      • NOAC
      • Acetylsalicylic Acid
      • Calgary, Alberta, Canada
      • +8 more
      Mar 18, 2020

      Atrial Fibrillation, Anticoagulants and Bleeding Disorders Trial in Netherlands (Left atrial appendage occlusion (Watchman FLX

      Recruiting
      • Atrial Fibrillation
      • Anticoagulants and Bleeding Disorders
      • Left atrial appendage occlusion (Watchman FLX or Amplatzer Amulet)
      • Leeuwarden, Friesland, Netherlands
      • +13 more
      Dec 19, 2022

      Atrial Fibrillation Trial in Seoul (NOAC monotherapy, Dual therapy with apixaban and clopidogrel)

      Recruiting
      • Atrial Fibrillation
      • NOAC monotherapy
      • Dual therapy with apixaban and clopidogrel
      • Seoul, Korea, Republic of
        Severance Cardiovascular Hospital, Yonsei University Health Syst
      Sep 10, 2021